Home
    Disclaimer

    Zolpidem

    Aliases: Ambien, Edluar, Stilnox, Stilnoct, Sublinox

    Summary TheDrug.Wiki Erowid TripSit PsychonautWiki

    Zolpidem (also known as Ambien, Intermezzo, Edluar, Stilnoct, Stilnox, Zolpimist, and others) is a non-benzodiazepine hypnotic of the imidazopyridine chemical class which is primarily used in the treatment of insomnia. When taken at recreational doses, it reportedly produces powerful and notoriously bizarre atypical hallucinogenic, dissociative, deliriant and even psychedelic effects. Zolpidem is a member of a family colloquially known as a "Z-drug." Other Z-drugs include zaleplon (Sonata) and zopiclone (Imovane).

    Dose Information TheDrug.Wiki TripSit PsychonautWiki

    ROA Light Common Strong Heavy
    Oral 10-20mg 20-30mg 30-50mg 50mg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit PsychonautWiki

    ROA Onset Comeup Peak Offset After Effects Total
    Oral 15-45 min 30-45 min 3-6 hrs 4-5 hrs 2-4 hrs 7.75-12.5 hrs

    Effect Profile

    425 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Validated against 354 Erowid trip reports
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Psychedelic 5.8
    Strong 6/10

    Strong auditory effects with moderate visuals, mild headspace and body load

    Visual Intensity ×3
    6
    drifting
    Headspace Depth ×3
    4
    delusions time distortion
    Auditory Effects ×1
    10
    auditory hallucinations auditory hallucination
    Body Load / Somatic Effects ×1
    4
    nausea

    Tolerance

    Build-up develops within 1–2 weeks of nightly use; cross-tolerant with benzodiazepines
    Reset 1–2 weeks; rebound insomnia common

    Tolerance Decay

    Full tolerance 14d Half tolerance 7d Baseline ~21d

    Builds quickly with nightly use; partial tolerance to sedative and amnestic effects may develop within 2–4 weeks, while psychomotor impairment and disinhibition can persist. After cessation, tolerance decays over 2–4 weeks in most people, but residual sleep disruption can persist. Data quality mixed; clinical trials and case reports suggest cross‑tolerance with benzodiazepines via shared GABAA BZ site.

    Effects Erowid Bluelight

    Aggregated from 354 Erowid and 71 Bluelight experience reports

    Positive Effects 44

    Sedation 32.6% 87%
    Stimulation 29.2% 78%
    Anxiety Suppression 23.0% 85%
    Euphoria 21.1% 84%
    Empathy 17.5% 70%
    Color Enhancement 16.6% 79%
    Melting/flowing 14.0% 79%
    Open-Eye Visuals 13.9% 88%
    Music Enhancement 13.9% 83%
    Tactile Enhancement 11.6% 70%
    Joy 10.0% 79%
    Contentment 10.0% 82%
    Focus Enhancement 9.6% 70%
    Closed-Eye Visuals 8.4% 82%
    Visual Trails 8.0% 86%
    Vivid Dreams 8.0% 88%
    Lightness 8.0% 79%
    Meta-Awareness Of Irrationality 6.0% 78%
    Emotional Openness 6.0% 78%
    Body High 4.5% 77%

    Adverse Effects 47

    Amnesia 56.0% 89%
    Thought Disorganization 30.0% 80%
    Memory Suppression 25.0% 91%
    Body Load 22.0% 72%
    Confusion 21.0% 88%
    Ataxia 20.0% 84%
    Double Vision 18.0% 86%
    Motor Impairment 17.8% 83%
    Dizziness 14.0% 83%
    Pareidolia 12.0% 84%
    Disinhibition 12.0% 86%
    Vomiting 12.0% 92%
    Nausea 10.9% 80%
    Auditory Effects 10.1% 88%
    Jaw Clenching 8.0% 82%
    Fear 8.0% 91%
    Delusion 8.0% 84%
    Panic 6.0% 87%
    Headache 5.0% 75%
    Dysphoria 4.0% 85%

    Combinations TripSit

    Pill Identifiers

    Helpful Links